Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Strabismus | 51 | 2024 | 287 | 15.780 |
Why?
|
Amblyopia | 28 | 2023 | 143 | 12.150 |
Why?
|
Oculomotor Muscles | 50 | 2024 | 371 | 10.990 |
Why?
|
Ophthalmologic Surgical Procedures | 34 | 2024 | 349 | 8.230 |
Why?
|
Esotropia | 21 | 2024 | 91 | 6.510 |
Why?
|
Vision, Binocular | 37 | 2024 | 213 | 6.200 |
Why?
|
Ophthalmology | 13 | 2023 | 508 | 4.620 |
Why?
|
Duane Retraction Syndrome | 9 | 2020 | 60 | 3.560 |
Why?
|
Diplopia | 14 | 2024 | 200 | 3.260 |
Why?
|
Vision Screening | 8 | 2024 | 66 | 3.240 |
Why?
|
Ophthalmoplegia | 10 | 2021 | 166 | 2.770 |
Why?
|
Visual Acuity | 27 | 2023 | 2530 | 2.270 |
Why?
|
Eyeglasses | 7 | 2021 | 145 | 2.020 |
Why?
|
Suture Techniques | 12 | 2022 | 798 | 1.990 |
Why?
|
Eye Movements | 11 | 2022 | 507 | 1.910 |
Why?
|
Botulinum Toxins, Type A | 6 | 2024 | 213 | 1.780 |
Why?
|
Refractive Errors | 4 | 2023 | 142 | 1.770 |
Why?
|
Botulinum Toxins | 4 | 2022 | 191 | 1.690 |
Why?
|
Sensory Deprivation | 6 | 2023 | 109 | 1.510 |
Why?
|
Neuromuscular Agents | 3 | 2022 | 134 | 1.500 |
Why?
|
Fibrosis | 10 | 2021 | 2029 | 1.380 |
Why?
|
Diagnostic Techniques, Ophthalmological | 6 | 2020 | 245 | 1.360 |
Why?
|
Anisometropia | 2 | 2022 | 13 | 1.360 |
Why?
|
Ocular Motility Disorders | 6 | 2019 | 135 | 1.340 |
Why?
|
Exotropia | 7 | 2024 | 55 | 1.280 |
Why?
|
Myokymia | 2 | 2017 | 11 | 1.260 |
Why?
|
Trochlear Nerve Diseases | 2 | 2017 | 15 | 1.250 |
Why?
|
Tubulin | 7 | 2021 | 695 | 1.190 |
Why?
|
Mydriatics | 4 | 2020 | 68 | 1.180 |
Why?
|
Atropine | 3 | 2020 | 244 | 1.120 |
Why?
|
Vision Tests | 9 | 2023 | 167 | 1.090 |
Why?
|
Depth Perception | 7 | 2019 | 94 | 1.060 |
Why?
|
Optics and Photonics | 4 | 2014 | 321 | 1.050 |
Why?
|
Child | 72 | 2024 | 77709 | 0.960 |
Why?
|
Child, Preschool | 47 | 2024 | 41006 | 0.910 |
Why?
|
Tendons | 3 | 2019 | 548 | 0.890 |
Why?
|
Carbon Footprint | 1 | 2022 | 15 | 0.870 |
Why?
|
Coloboma | 4 | 2003 | 54 | 0.840 |
Why?
|
Accommodation, Ocular | 4 | 2018 | 48 | 0.830 |
Why?
|
Abducens Nerve Diseases | 3 | 2024 | 43 | 0.810 |
Why?
|
Capital Financing | 1 | 2021 | 58 | 0.800 |
Why?
|
Blepharospasm | 1 | 2021 | 30 | 0.760 |
Why?
|
Video Games | 3 | 2021 | 184 | 0.760 |
Why?
|
Sclera | 4 | 2023 | 200 | 0.740 |
Why?
|
Tenotomy | 1 | 2019 | 49 | 0.700 |
Why?
|
Vision Disorders | 6 | 2019 | 1058 | 0.690 |
Why?
|
Biotechnology | 1 | 2021 | 281 | 0.690 |
Why?
|
Oculomotor Nerve Diseases | 4 | 2023 | 48 | 0.690 |
Why?
|
Orthoptics | 3 | 2021 | 10 | 0.680 |
Why?
|
Intraoperative Complications | 3 | 2014 | 1198 | 0.650 |
Why?
|
Retinal Dysplasia | 1 | 2018 | 15 | 0.650 |
Why?
|
Humans | 160 | 2024 | 744343 | 0.650 |
Why?
|
Walker-Warburg Syndrome | 1 | 2018 | 14 | 0.650 |
Why?
|
Sutures | 4 | 2016 | 299 | 0.640 |
Why?
|
Levobunolol | 1 | 2017 | 3 | 0.640 |
Why?
|
Sympatholytics | 1 | 2017 | 83 | 0.630 |
Why?
|
Bandages | 1 | 2020 | 266 | 0.630 |
Why?
|
Academies and Institutes | 1 | 2020 | 317 | 0.610 |
Why?
|
Fellowships and Scholarships | 3 | 2023 | 1076 | 0.600 |
Why?
|
Lens Implantation, Intraocular | 3 | 2013 | 192 | 0.600 |
Why?
|
Central Serous Chorioretinopathy | 1 | 2017 | 27 | 0.590 |
Why?
|
Pediatrics | 4 | 2022 | 3475 | 0.590 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2018 | 171 | 0.580 |
Why?
|
Mobius Syndrome | 5 | 2021 | 40 | 0.570 |
Why?
|
Infant | 30 | 2023 | 35136 | 0.570 |
Why?
|
Sports | 1 | 2023 | 688 | 0.570 |
Why?
|
Diagnosis, Computer-Assisted | 4 | 2006 | 719 | 0.560 |
Why?
|
Phacoemulsification | 2 | 2013 | 149 | 0.560 |
Why?
|
Cicatrix | 1 | 2022 | 764 | 0.550 |
Why?
|
Retrospective Studies | 36 | 2024 | 77449 | 0.550 |
Why?
|
Myasthenia Gravis | 1 | 2018 | 199 | 0.520 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2017 | 1240 | 0.510 |
Why?
|
Fixation, Ocular | 6 | 2011 | 251 | 0.500 |
Why?
|
Eye Diseases | 3 | 2007 | 669 | 0.500 |
Why?
|
Treatment Outcome | 27 | 2024 | 63114 | 0.470 |
Why?
|
Optic Disk | 3 | 2003 | 400 | 0.470 |
Why?
|
Osteogenesis Imperfecta | 1 | 2014 | 83 | 0.470 |
Why?
|
Blepharoptosis | 3 | 2014 | 143 | 0.470 |
Why?
|
Eye Injuries | 2 | 2014 | 245 | 0.460 |
Why?
|
Pterygium | 2 | 2023 | 26 | 0.450 |
Why?
|
Lens, Crystalline | 3 | 2024 | 388 | 0.440 |
Why?
|
Homeodomain Proteins | 4 | 2019 | 2421 | 0.440 |
Why?
|
Pseudophakia | 1 | 2013 | 62 | 0.440 |
Why?
|
Computers, Handheld | 1 | 2015 | 208 | 0.440 |
Why?
|
Optic Nerve | 5 | 2011 | 554 | 0.440 |
Why?
|
Follow-Up Studies | 19 | 2024 | 39050 | 0.430 |
Why?
|
Conscious Sedation | 1 | 2017 | 528 | 0.430 |
Why?
|
Internship and Residency | 2 | 2022 | 5788 | 0.410 |
Why?
|
Brain Concussion | 1 | 2023 | 1320 | 0.410 |
Why?
|
Male | 76 | 2023 | 350118 | 0.390 |
Why?
|
Brain Injuries | 1 | 2023 | 2025 | 0.380 |
Why?
|
Propofol | 1 | 2017 | 629 | 0.380 |
Why?
|
Adolescent | 36 | 2024 | 85781 | 0.370 |
Why?
|
Cataract | 4 | 2024 | 834 | 0.360 |
Why?
|
Postoperative Complications | 8 | 2018 | 15295 | 0.360 |
Why?
|
Female | 74 | 2024 | 380194 | 0.350 |
Why?
|
Periodicals as Topic | 2 | 2011 | 1432 | 0.340 |
Why?
|
Hypnotics and Sedatives | 1 | 2017 | 1162 | 0.340 |
Why?
|
Pinealoma | 1 | 2009 | 54 | 0.330 |
Why?
|
Mutation | 12 | 2022 | 29786 | 0.330 |
Why?
|
Germinoma | 1 | 2009 | 133 | 0.320 |
Why?
|
Reoperation | 8 | 2024 | 4201 | 0.320 |
Why?
|
Injections, Intramuscular | 3 | 2018 | 552 | 0.310 |
Why?
|
Syndrome | 8 | 2021 | 3251 | 0.310 |
Why?
|
Education | 1 | 2010 | 543 | 0.280 |
Why?
|
Abnormalities, Multiple | 3 | 2021 | 1416 | 0.280 |
Why?
|
United States Agency for Healthcare Research and Quality | 1 | 2006 | 92 | 0.280 |
Why?
|
Vision, Monocular | 2 | 1999 | 78 | 0.280 |
Why?
|
Kidney | 4 | 2003 | 7186 | 0.280 |
Why?
|
Polyesters | 1 | 2008 | 363 | 0.280 |
Why?
|
Anesthesia, Local | 2 | 2001 | 275 | 0.280 |
Why?
|
Dyslexia | 2 | 2019 | 248 | 0.280 |
Why?
|
Malformations of Cortical Development | 2 | 2021 | 200 | 0.280 |
Why?
|
Tomography, Optical Coherence | 1 | 2018 | 2657 | 0.270 |
Why?
|
Lenses, Intraocular | 2 | 2001 | 140 | 0.270 |
Why?
|
Myopia | 2 | 2018 | 254 | 0.270 |
Why?
|
Thigh | 1 | 2007 | 247 | 0.270 |
Why?
|
Visually Impaired Persons | 1 | 2006 | 81 | 0.270 |
Why?
|
Migraine Disorders | 1 | 2018 | 1620 | 0.260 |
Why?
|
Eye Diseases, Hereditary | 3 | 2015 | 117 | 0.260 |
Why?
|
Graves Ophthalmopathy | 2 | 2023 | 117 | 0.260 |
Why?
|
Nystagmus, Pathologic | 2 | 2011 | 96 | 0.260 |
Why?
|
Birefringence | 3 | 2006 | 56 | 0.250 |
Why?
|
Photometry | 1 | 2004 | 58 | 0.250 |
Why?
|
Adult | 40 | 2024 | 214055 | 0.250 |
Why?
|
Retinal Diseases | 3 | 2001 | 683 | 0.240 |
Why?
|
Facial Paralysis | 2 | 2021 | 338 | 0.230 |
Why?
|
Acetylcholinesterase | 1 | 2023 | 153 | 0.220 |
Why?
|
Scleral Buckling | 2 | 2022 | 84 | 0.220 |
Why?
|
Lacrimal Duct Obstruction | 1 | 2023 | 48 | 0.220 |
Why?
|
Blinking | 2 | 2005 | 138 | 0.210 |
Why?
|
Dacryocystorhinostomy | 1 | 2023 | 72 | 0.210 |
Why?
|
Nasolacrimal Duct | 1 | 2023 | 74 | 0.210 |
Why?
|
Convergence, Ocular | 2 | 2019 | 24 | 0.210 |
Why?
|
Insurance | 1 | 2023 | 111 | 0.210 |
Why?
|
Anesthetics, Combined | 1 | 2001 | 40 | 0.200 |
Why?
|
Hyperopia | 1 | 2001 | 44 | 0.200 |
Why?
|
Anesthetics, Local | 2 | 2001 | 985 | 0.200 |
Why?
|
Vision, Low | 1 | 2023 | 168 | 0.200 |
Why?
|
Radiation Injuries | 1 | 2009 | 1180 | 0.200 |
Why?
|
Arthrogryposis | 1 | 2022 | 72 | 0.200 |
Why?
|
Child Health Services | 1 | 2007 | 667 | 0.190 |
Why?
|
Crystallins | 1 | 2020 | 75 | 0.190 |
Why?
|
Sensitivity and Specificity | 6 | 2021 | 14722 | 0.190 |
Why?
|
Lost to Follow-Up | 1 | 2021 | 105 | 0.190 |
Why?
|
Macula Lutea | 1 | 2001 | 151 | 0.190 |
Why?
|
Cross-Sectional Studies | 9 | 2024 | 25043 | 0.190 |
Why?
|
Down Syndrome | 2 | 2024 | 880 | 0.180 |
Why?
|
Muscle, Skeletal | 3 | 2022 | 4931 | 0.180 |
Why?
|
Visual Perception | 1 | 2009 | 1420 | 0.180 |
Why?
|
Nystagmus, Congenital | 2 | 2012 | 7 | 0.180 |
Why?
|
Investments | 1 | 2021 | 143 | 0.180 |
Why?
|
Eye Abnormalities | 1 | 2002 | 246 | 0.180 |
Why?
|
Anesthesia | 1 | 2011 | 1561 | 0.180 |
Why?
|
Health Care Sector | 1 | 2021 | 194 | 0.180 |
Why?
|
Gonioscopy | 1 | 1999 | 157 | 0.170 |
Why?
|
Ophthalmic Solutions | 2 | 2020 | 317 | 0.170 |
Why?
|
Equipment Design | 6 | 2006 | 3582 | 0.170 |
Why?
|
Middle Aged | 26 | 2023 | 213383 | 0.170 |
Why?
|
Anterior Chamber | 1 | 1999 | 197 | 0.170 |
Why?
|
Equipment Failure Analysis | 4 | 2006 | 868 | 0.170 |
Why?
|
Refraction, Ocular | 3 | 2006 | 182 | 0.170 |
Why?
|
Health Services Research | 1 | 2006 | 1836 | 0.160 |
Why?
|
Sickness Impact Profile | 1 | 2020 | 302 | 0.160 |
Why?
|
Photography | 2 | 1999 | 520 | 0.160 |
Why?
|
Exudates and Transudates | 1 | 1999 | 172 | 0.160 |
Why?
|
Choroidal Neovascularization | 1 | 2001 | 343 | 0.160 |
Why?
|
Reading | 2 | 2018 | 558 | 0.160 |
Why?
|
Young Adult | 15 | 2024 | 56430 | 0.160 |
Why?
|
Mutation, Missense | 5 | 2021 | 2564 | 0.160 |
Why?
|
Carbon Dioxide | 1 | 2022 | 1150 | 0.160 |
Why?
|
PAX2 Transcription Factor | 3 | 2002 | 80 | 0.160 |
Why?
|
Amino Acid Substitution | 4 | 2021 | 1791 | 0.160 |
Why?
|
Fluorescein Angiography | 2 | 2018 | 940 | 0.150 |
Why?
|
Schools | 2 | 2024 | 1433 | 0.150 |
Why?
|
Anterior Eye Segment | 1 | 2018 | 152 | 0.150 |
Why?
|
Evidence-Based Medicine | 1 | 2010 | 3610 | 0.150 |
Why?
|
Glaucoma, Angle-Closure | 1 | 1999 | 189 | 0.150 |
Why?
|
Retinopathy of Prematurity | 2 | 1993 | 421 | 0.150 |
Why?
|
Acute Disease | 2 | 2019 | 7149 | 0.150 |
Why?
|
Iris | 1 | 2018 | 239 | 0.150 |
Why?
|
Neurotoxins | 1 | 2018 | 237 | 0.150 |
Why?
|
Vitreous Body | 1 | 1999 | 389 | 0.140 |
Why?
|
Light | 3 | 2010 | 1374 | 0.140 |
Why?
|
Craniofacial Abnormalities | 1 | 1999 | 315 | 0.140 |
Why?
|
Health Expenditures | 2 | 2023 | 2348 | 0.140 |
Why?
|
Refractometry | 2 | 2007 | 56 | 0.140 |
Why?
|
Diagnosis, Differential | 4 | 2018 | 12959 | 0.140 |
Why?
|
MafB Transcription Factor | 1 | 2016 | 25 | 0.140 |
Why?
|
Ankle Joint | 1 | 2000 | 411 | 0.140 |
Why?
|
Diffusion of Innovation | 1 | 2021 | 725 | 0.140 |
Why?
|
Travel | 1 | 2022 | 788 | 0.140 |
Why?
|
Aged | 16 | 2021 | 163280 | 0.140 |
Why?
|
Cataract Extraction | 2 | 2005 | 481 | 0.140 |
Why?
|
Nose | 2 | 2022 | 509 | 0.140 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2021 | 685 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2024 | 1941 | 0.130 |
Why?
|
Retinal Vessels | 1 | 2001 | 772 | 0.130 |
Why?
|
Reproducibility of Results | 8 | 2014 | 19905 | 0.130 |
Why?
|
Athletes | 1 | 2023 | 1093 | 0.130 |
Why?
|
Labyrinth Diseases | 1 | 2016 | 150 | 0.130 |
Why?
|
Cohort Studies | 6 | 2024 | 40561 | 0.130 |
Why?
|
Ophthalmoplegia, Chronic Progressive External | 1 | 2013 | 17 | 0.120 |
Why?
|
Anesthetics, Intravenous | 1 | 2017 | 417 | 0.120 |
Why?
|
Risk Factors | 9 | 2023 | 72290 | 0.120 |
Why?
|
Spermatozoa | 3 | 1988 | 625 | 0.120 |
Why?
|
Pedigree | 8 | 2016 | 4644 | 0.110 |
Why?
|
Education, Medical, Graduate | 2 | 2023 | 2291 | 0.110 |
Why?
|
Retinitis Pigmentosa | 2 | 1988 | 386 | 0.110 |
Why?
|
Aged, 80 and over | 10 | 2018 | 57776 | 0.110 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2018 | 602 | 0.110 |
Why?
|
Glaucoma, Open-Angle | 1 | 1999 | 706 | 0.110 |
Why?
|
Cytoskeletal Proteins | 2 | 2011 | 1364 | 0.110 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2000 | 1534 | 0.110 |
Why?
|
Contracture | 1 | 1995 | 223 | 0.110 |
Why?
|
Patient Satisfaction | 3 | 2023 | 3396 | 0.100 |
Why?
|
Iris Diseases | 1 | 1992 | 40 | 0.100 |
Why?
|
Infant, Newborn | 8 | 2019 | 25625 | 0.100 |
Why?
|
Kallmann Syndrome | 1 | 2013 | 140 | 0.100 |
Why?
|
Chimerin 1 | 1 | 2011 | 14 | 0.100 |
Why?
|
Pain | 1 | 2007 | 4986 | 0.100 |
Why?
|
Electromyography | 1 | 1996 | 1379 | 0.100 |
Why?
|
Head Movements | 1 | 2012 | 150 | 0.100 |
Why?
|
Retina | 3 | 2006 | 2616 | 0.100 |
Why?
|
Laser Coagulation | 1 | 1993 | 326 | 0.090 |
Why?
|
Blindness | 1 | 1995 | 617 | 0.090 |
Why?
|
General Surgery | 1 | 2022 | 1636 | 0.090 |
Why?
|
Transcription Factors | 5 | 2014 | 12208 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2002 | 9648 | 0.090 |
Why?
|
Ophthalmic Nerve | 2 | 2011 | 43 | 0.090 |
Why?
|
Foreign-Body Migration | 1 | 1992 | 222 | 0.090 |
Why?
|
United States | 5 | 2023 | 69872 | 0.090 |
Why?
|
DNA Mutational Analysis | 6 | 2014 | 4186 | 0.090 |
Why?
|
Ischemia | 1 | 2018 | 1907 | 0.090 |
Why?
|
Kidney Diseases | 1 | 2001 | 2149 | 0.090 |
Why?
|
Vomiting | 1 | 2013 | 636 | 0.090 |
Why?
|
Patient Compliance | 1 | 2020 | 2684 | 0.090 |
Why?
|
Prospective Studies | 8 | 2023 | 53288 | 0.090 |
Why?
|
Nervous System Diseases | 1 | 1999 | 1622 | 0.080 |
Why?
|
Delivery of Health Care | 1 | 2007 | 5319 | 0.080 |
Why?
|
False Positive Reactions | 1 | 2011 | 981 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 765 | 0.080 |
Why?
|
Databases, Factual | 2 | 2023 | 7729 | 0.080 |
Why?
|
Visual Cortex | 1 | 2017 | 1149 | 0.080 |
Why?
|
Genetic Linkage | 3 | 2011 | 2421 | 0.080 |
Why?
|
Photoreceptor Cells | 2 | 1988 | 244 | 0.080 |
Why?
|
Needlestick Injuries | 2 | 2001 | 67 | 0.080 |
Why?
|
Trochlear Nerve | 1 | 2008 | 25 | 0.080 |
Why?
|
Neuronal Plasticity | 1 | 2017 | 1422 | 0.080 |
Why?
|
Antithyroid Agents | 1 | 2008 | 70 | 0.080 |
Why?
|
Pilot Projects | 1 | 2021 | 8324 | 0.080 |
Why?
|
Pandemics | 3 | 2023 | 8388 | 0.080 |
Why?
|
Neuromuscular Blockade | 1 | 2009 | 146 | 0.080 |
Why?
|
Oculomotor Nerve | 1 | 2008 | 74 | 0.080 |
Why?
|
User-Computer Interface | 2 | 2004 | 1431 | 0.080 |
Why?
|
Pupil | 2 | 1999 | 149 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.080 |
Why?
|
Alzheimer Disease | 2 | 2024 | 8037 | 0.080 |
Why?
|
Synapses | 1 | 2017 | 1728 | 0.070 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2011 | 372 | 0.070 |
Why?
|
Retinoscopes | 1 | 2006 | 3 | 0.070 |
Why?
|
Clinical Competence | 1 | 2022 | 4687 | 0.070 |
Why?
|
Scoliosis | 1 | 2013 | 725 | 0.070 |
Why?
|
Fovea Centralis | 1 | 2007 | 119 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2006 | 5078 | 0.070 |
Why?
|
Sperm Tail | 1 | 1986 | 18 | 0.070 |
Why?
|
Genes, X-Linked | 1 | 2006 | 128 | 0.070 |
Why?
|
Logistic Models | 1 | 2021 | 13408 | 0.070 |
Why?
|
Prognosis | 4 | 2017 | 29063 | 0.070 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2012 | 770 | 0.070 |
Why?
|
Transducers | 1 | 2007 | 252 | 0.070 |
Why?
|
Lidocaine | 2 | 2001 | 544 | 0.070 |
Why?
|
Prevalence | 4 | 2023 | 15226 | 0.060 |
Why?
|
Phenotype | 6 | 2024 | 16365 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2012 | 1312 | 0.060 |
Why?
|
Bupivacaine | 2 | 2001 | 411 | 0.060 |
Why?
|
Fundus Oculi | 2 | 1999 | 473 | 0.060 |
Why?
|
Public Health | 1 | 2018 | 2603 | 0.060 |
Why?
|
Puberty | 1 | 2008 | 490 | 0.060 |
Why?
|
Amyloid beta-Peptides | 2 | 2024 | 3587 | 0.060 |
Why?
|
X Chromosome | 1 | 1988 | 814 | 0.060 |
Why?
|
Intraoperative Care | 1 | 2008 | 767 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
Goals | 2 | 2023 | 706 | 0.060 |
Why?
|
Posture | 1 | 2008 | 958 | 0.060 |
Why?
|
Quality Indicators, Health Care | 1 | 2014 | 1831 | 0.060 |
Why?
|
Publishing | 1 | 2011 | 833 | 0.060 |
Why?
|
ROC Curve | 1 | 2011 | 3527 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2018 | 5853 | 0.060 |
Why?
|
Eyelids | 1 | 2005 | 265 | 0.060 |
Why?
|
Nerve Tissue Proteins | 2 | 2007 | 4462 | 0.060 |
Why?
|
Aging | 2 | 2020 | 8664 | 0.060 |
Why?
|
Registries | 3 | 2024 | 8089 | 0.060 |
Why?
|
Models, Biological | 1 | 1999 | 9583 | 0.050 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.050 |
Why?
|
Intubation | 1 | 2023 | 141 | 0.050 |
Why?
|
Head | 1 | 2008 | 880 | 0.050 |
Why?
|
Radiotherapy Dosage | 1 | 2009 | 2879 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3133 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3240 | 0.050 |
Why?
|
Membrane Proteins | 2 | 2011 | 7880 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 1988 | 1813 | 0.050 |
Why?
|
Tissue Transplantation | 1 | 2001 | 130 | 0.050 |
Why?
|
Pliability | 1 | 2000 | 63 | 0.050 |
Why?
|
Histidine | 1 | 2021 | 313 | 0.050 |
Why?
|
Fertility | 1 | 1986 | 781 | 0.050 |
Why?
|
Paralysis | 1 | 2022 | 247 | 0.050 |
Why?
|
Incidence | 2 | 2020 | 20947 | 0.050 |
Why?
|
Mandible | 1 | 2005 | 740 | 0.050 |
Why?
|
Mice | 4 | 2023 | 81183 | 0.050 |
Why?
|
Automation | 1 | 2003 | 584 | 0.050 |
Why?
|
Chronic Disease | 2 | 2024 | 9146 | 0.050 |
Why?
|
Organoids | 1 | 1986 | 701 | 0.040 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2001 | 233 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2018 | 8642 | 0.040 |
Why?
|
Conjunctiva | 1 | 2023 | 494 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 13881 | 0.040 |
Why?
|
Fourier Analysis | 1 | 2000 | 447 | 0.040 |
Why?
|
Indocyanine Green | 1 | 2001 | 239 | 0.040 |
Why?
|
Baltimore | 1 | 1999 | 231 | 0.040 |
Why?
|
Gene Duplication | 1 | 2020 | 329 | 0.040 |
Why?
|
Amino Acid Sequence | 4 | 2015 | 13815 | 0.040 |
Why?
|
Visual Field Tests | 1 | 2001 | 383 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2018 | 15519 | 0.040 |
Why?
|
Risk Assessment | 2 | 2014 | 23338 | 0.040 |
Why?
|
Orthokeratologic Procedures | 1 | 2018 | 6 | 0.040 |
Why?
|
Evoked Potentials, Visual | 1 | 2001 | 427 | 0.040 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2020 | 712 | 0.040 |
Why?
|
Brazil | 1 | 2002 | 1270 | 0.040 |
Why?
|
Ciliary Body | 1 | 1999 | 173 | 0.040 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2020 | 1801 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2020 | 6171 | 0.040 |
Why?
|
Molecular Sequence Data | 4 | 2015 | 18111 | 0.040 |
Why?
|
Lighting | 1 | 2020 | 231 | 0.040 |
Why?
|
Arginine | 1 | 2021 | 944 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2023 | 594 | 0.040 |
Why?
|
Animals | 6 | 2023 | 168757 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2018 | 35421 | 0.040 |
Why?
|
Cryosurgery | 2 | 1993 | 453 | 0.040 |
Why?
|
Visual Fields | 2 | 2001 | 1047 | 0.040 |
Why?
|
Markov Chains | 1 | 2020 | 969 | 0.040 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 230 | 0.040 |
Why?
|
Renal Insufficiency | 1 | 2002 | 804 | 0.040 |
Why?
|
Contact Lenses | 1 | 2018 | 145 | 0.040 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 397 | 0.040 |
Why?
|
Biometry | 1 | 1999 | 558 | 0.030 |
Why?
|
Health Surveys | 1 | 2006 | 4037 | 0.030 |
Why?
|
Critical Illness | 1 | 2009 | 2670 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 21746 | 0.030 |
Why?
|
Face | 1 | 2022 | 994 | 0.030 |
Why?
|
Confidentiality | 1 | 2020 | 612 | 0.030 |
Why?
|
Biomedical Research | 1 | 2011 | 3309 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2011 | 15076 | 0.030 |
Why?
|
Drug Therapy | 1 | 2018 | 497 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 40075 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2020 | 2187 | 0.030 |
Why?
|
Microscopy, Electron | 3 | 1988 | 2645 | 0.030 |
Why?
|
Sperm Motility | 2 | 1986 | 253 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2400 | 0.030 |
Why?
|
Heterozygote | 1 | 2021 | 2804 | 0.030 |
Why?
|
Vitamin E | 2 | 1992 | 869 | 0.030 |
Why?
|
Students | 1 | 2024 | 1654 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2007 | 3327 | 0.030 |
Why?
|
Documentation | 1 | 2020 | 871 | 0.030 |
Why?
|
Drug Synergism | 1 | 2018 | 1792 | 0.030 |
Why?
|
Observer Variation | 1 | 1999 | 2593 | 0.030 |
Why?
|
Neurons | 1 | 2013 | 9338 | 0.030 |
Why?
|
Injections | 1 | 1996 | 840 | 0.030 |
Why?
|
Gene Frequency | 1 | 2020 | 3588 | 0.030 |
Why?
|
Socioeconomic Factors | 1 | 2007 | 7785 | 0.030 |
Why?
|
Linear Models | 1 | 2023 | 5952 | 0.030 |
Why?
|
Light Coagulation | 1 | 1992 | 72 | 0.030 |
Why?
|
Eye Banks | 1 | 2012 | 38 | 0.030 |
Why?
|
Binding Sites | 1 | 2021 | 6114 | 0.030 |
Why?
|
Abducens Nerve | 1 | 2011 | 28 | 0.030 |
Why?
|
Microtubules | 2 | 2010 | 1090 | 0.030 |
Why?
|
Founder Effect | 1 | 2012 | 189 | 0.030 |
Why?
|
Vaccination | 1 | 2024 | 3278 | 0.030 |
Why?
|
Myofibrils | 1 | 2012 | 146 | 0.020 |
Why?
|
Nystagmus, Optokinetic | 1 | 2011 | 31 | 0.020 |
Why?
|
Surface-Active Agents | 1 | 1992 | 159 | 0.020 |
Why?
|
Haplorhini | 1 | 2012 | 552 | 0.020 |
Why?
|
Nutrition Surveys | 1 | 2018 | 1660 | 0.020 |
Why?
|
Silicones | 1 | 1992 | 250 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2015 | 2839 | 0.020 |
Why?
|
Cranial Nerve Diseases | 1 | 2011 | 112 | 0.020 |
Why?
|
Brain | 4 | 2011 | 26385 | 0.020 |
Why?
|
rac GTP-Binding Proteins | 1 | 2011 | 164 | 0.020 |
Why?
|
Models, Molecular | 2 | 2012 | 5456 | 0.020 |
Why?
|
Recurrence | 1 | 2022 | 8340 | 0.020 |
Why?
|
Reflex, Vestibulo-Ocular | 1 | 2011 | 85 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2011 | 326 | 0.020 |
Why?
|
Forecasting | 1 | 1999 | 2951 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2016 | 1701 | 0.020 |
Why?
|
Cornea | 1 | 1998 | 1524 | 0.020 |
Why?
|
Health Care Costs | 1 | 2023 | 3209 | 0.020 |
Why?
|
Neuromuscular Junction | 1 | 2012 | 398 | 0.020 |
Why?
|
Semicircular Canals | 1 | 2011 | 198 | 0.020 |
Why?
|
Eye Protective Devices | 1 | 2009 | 33 | 0.020 |
Why?
|
Genotype | 1 | 2024 | 12951 | 0.020 |
Why?
|
Lubricants | 1 | 2009 | 31 | 0.020 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 436 | 0.020 |
Why?
|
Vitrectomy | 1 | 1992 | 365 | 0.020 |
Why?
|
Base Sequence | 2 | 2012 | 12797 | 0.020 |
Why?
|
Scattering, Radiation | 1 | 2010 | 498 | 0.020 |
Why?
|
Infant, Low Birth Weight | 1 | 1993 | 850 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2005 | 9959 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3558 | 0.020 |
Why?
|
Motor Neurons | 1 | 2012 | 844 | 0.020 |
Why?
|
Physician-Patient Relations | 1 | 2020 | 3229 | 0.020 |
Why?
|
Eye Proteins | 1 | 2010 | 646 | 0.020 |
Why?
|
Ultrasonography | 1 | 1999 | 5985 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2012 | 1783 | 0.020 |
Why?
|
Models, Theoretical | 1 | 1998 | 3589 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 8987 | 0.020 |
Why?
|
Chromosomes, Human | 1 | 1988 | 457 | 0.020 |
Why?
|
Family Health | 1 | 2011 | 1282 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
Chromosome Disorders | 1 | 1988 | 514 | 0.020 |
Why?
|
Inheritance Patterns | 1 | 2007 | 340 | 0.020 |
Why?
|
Chromosomes, Human, X | 1 | 2006 | 296 | 0.020 |
Why?
|
Genes, Dominant | 1 | 2007 | 880 | 0.020 |
Why?
|
Gestational Age | 1 | 1993 | 3493 | 0.010 |
Why?
|
Protein Transport | 1 | 2010 | 1988 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 1988 | 748 | 0.010 |
Why?
|
Fetus | 1 | 2011 | 1880 | 0.010 |
Why?
|
Motion | 1 | 2006 | 798 | 0.010 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2009 | 981 | 0.010 |
Why?
|
Cilia | 1 | 1986 | 466 | 0.010 |
Why?
|
Axons | 1 | 2010 | 1684 | 0.010 |
Why?
|
Developmental Disabilities | 1 | 2010 | 1456 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2016 | 14557 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2007 | 3846 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
Cyclopentolate | 1 | 1999 | 6 | 0.010 |
Why?
|
Propoxycaine | 1 | 1999 | 6 | 0.010 |
Why?
|
Tropicamide | 1 | 1999 | 23 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2018 | 12261 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2012 | 7722 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4740 | 0.010 |
Why?
|
Administration, Topical | 1 | 1999 | 690 | 0.010 |
Why?
|
Aerosols | 1 | 1999 | 625 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2006 | 3617 | 0.010 |
Why?
|
Single-Blind Method | 1 | 1999 | 1590 | 0.010 |
Why?
|
Infant, Premature | 1 | 1984 | 2044 | 0.010 |
Why?
|
Drug Combinations | 1 | 1999 | 1959 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2011 | 12072 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 21827 | 0.010 |
Why?
|
Age Factors | 1 | 2008 | 18370 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2008 | 15540 | 0.010 |
Why?
|
Pain Measurement | 1 | 1999 | 3420 | 0.010 |
Why?
|